CD133 and CD44 as cancer stem cell markers in bladder carcinoma: an immunohistochemical study
Conclusion
CD44 and CD133 could be considered as markers predicting poor prognosis in bladder carcinoma. Both markers were significantly related to higher tumor grade and the presence of muscle invasion.
Source: Egyptian Journal of Pathology - Category: Pathology Tags: Original Articles Source Type: research
More News: Bladder Cancer | Cancer | Cancer & Oncology | Cancer Therapy | Carcinoma | Egypt Health | Pathology | Stem Cell Therapy | Stem Cells | Study